{"id":5111,"date":"2023-11-01T07:24:16","date_gmt":"2023-11-01T12:24:16","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=5111"},"modified":"2023-11-01T07:24:19","modified_gmt":"2023-11-01T12:24:19","slug":"paxlovid-probably-wont-cut-your-odds-for-long-covid-study","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2023\/11\/01\/paxlovid-probably-wont-cut-your-odds-for-long-covid-study\/","title":{"rendered":"Paxlovid Probably Won&#8217;t Cut Your Odds for Long COVID: Study"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p><a href=\"https:\/\/www.healthday.com\/health-news\/coronavirus\/paxlovid-probably-wont-your-cut-odds-for-long-covid-study\">HealthDay<\/a> <\/p>\n\n\n\n<p>The antiviral drug Paxlovid is great at treating COVID-19 infections, but a new study casts doubt on its effectiveness at preventing symptoms associated with long COVID.<\/p>\n\n\n\n<p>Nearly 9,600 veterans given Paxlovid had about the same risk of most post-COVID side effects as vets not treated with the antiviral med, according to findings published Oct. 31 in the&nbsp;<em><a target=\"_blank\" href=\"https:\/\/www.acpjournals.org\/doi\/10.7326\/M23-1394\" rel=\"noreferrer noopener\">Annals of Internal Medicine<\/a><\/em>.<\/p>\n\n\n\n<p>The study suggests that otherwise healthy people infected with COVID might be wasting their time if they take Paxlovid to ward off long-term symptoms, said lead researcher&nbsp;<a target=\"_blank\" href=\"https:\/\/gastro.uw.edu\/people\/faculty\/ioannou-g\" rel=\"noreferrer noopener\">Dr. George Ioannou<\/a>, director of hepatology with the VA Puget Sound Health Care System in Seattle.<\/p>\n\n\n\n<p>Paxlovid (nirmatrelvir-ritonavir) is typically intended for COVID patients who are at high risk of dying or landing in the hospital, because they have existing health problems that make a severe infection more likely.<\/p>\n\n\n\n<p>\u201cIf the only reason you are taking Paxlovid is because you think it will prevent you from developing complications of COVID-19, then maybe you should think twice about that,\u201d Ioannou said.<\/p>\n<!-- <a rel=\"nofollow\" href=\"\/secure-location.php\" title=\"ur X  xh\">ur X  xh<\/a> --><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>HealthDay The antiviral drug Paxlovid is great at treating COVID-19 infections, but a new study casts doubt on its effectiveness at preventing symptoms associated with long COVID. Nearly 9,600 veterans given Paxlovid had about the same risk of most post-COVID side effects as vets not treated with the antiviral med, according to findings published Oct. [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":5112,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[14],"tags":[],"class_list":["post-5111","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science-and-tech"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-content\/uploads\/2023\/11\/Screenshot-2023-11-01-at-08.23.16.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/5111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=5111"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/5111\/revisions"}],"predecessor-version":[{"id":5113,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/5111\/revisions\/5113"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media\/5112"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=5111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=5111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=5111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}